Future work should further investigate the benefit of TOP1 and other inhibitors in treating lung cancer addicted to ETV4‐overexpressed transcription and replication across panels of cell lines, patient‐derived organoids, and in vivo experimental test. This evidence concerns the gene TOP1 and lung carcinoma.